Dr Biyani Manish
About
Dr. Manish R Biyani have combine expertise directing multiple initiatives simultaneously using strong time management and prioritization skills. Equipped with B pharm, M pharm (India) & PhD in Organic Chemistry at ๐๐ฒ๐ฟ๐ถ๐ผ๐-๐ช๐ฎ๐๐ ๐จ๐ป๐ถ๐๐ฒ๐ฟ๐๐ถ๐๐, ๐จ๐ alongside strong educational background in higher management. Accomplished 15 years of experience leading complex drug development and pharmaceutical manufacturing projects from concept development through to clinical trials and drug commercialization. Results-driven Pharma Leader with proven success fostering strong collaborative relationships with regulators, key stakeholders, and high-value clients in India, US, UK, Europe. Demonstrated ability to collaborate with stakeholders across R&D groups, quality, manufacturing, regulatory, clinical development, and SCM. Articulate communicator with credible history of cultivating positive partnerships with interdepartmental teams, management peers, and key clientele to realize strategic business goals.
Demonstrated capabilities in IPR, Corporate strategy, Project management, SCM, Technology evaluation, Digital transformation, Business intelligence (Data Analytics & Market research). He enables organization with project governance framework, multi-country patent strategy, business insights, Aligning business with Risk, Strategy & P & L
โบCommitted Project Management Professional with demonstrated expertise establishing project governance framework to plan, monitor, and control project deliverables, to identify and mitigate risks, and to complete projects on-time and within budget.
โบTrusted resource to executive leadership team in relation to multi-country patent strategy development and patent filing, being granted over ๐ญ๐๐ง ๐ฝ๐ฎ๐๐ฒ๐ป๐๐ in drug discovery and development.
โบCommitted Professional leveraging key market analysis skills to identify $ ๐ฎ๐ potential savings by competitive landscape
Strong background working in multiple start-ups & ability of exploring novel concepts in pharmaceutical, nutraceutical & food & beverage industries. As my professional career continues to evolve, I remain steadfast in my belief that collaboration is the key to business & thus committed to building positive relationships with interdepartmental teams, senior management, & key clientele. It is through these bonds that deals are closed and organizational goals are achieved.
Major areas of Research have been on Preclinical & clinical in drug-induced liver injury, anti-oxidant studies, Toxicological studies, CNS, immunology, neurobiology, addiction, DNA damage, oligonucleotide research, inflammation, & gout. Organic Chemistry experience in API process development, and multi-step NCE synthesis in areas such as nucleic acid synthesis, carbohydrates, macrolides (Antibiotics) and heterocyclic compounds & chiral separation (chiral auxiliaries & resolving agents).
Research interests
Top-100
Fields of science
|
1
|
|
|
Biochemistry
|
Biochemistry, 1, 33.33%
Biochemistry
1 publication, 33.33%
|
|
Medicine (miscellaneous)
|
Medicine (miscellaneous), 1, 33.33%
Medicine (miscellaneous)
1 publication, 33.33%
|
|
General Medicine
|
General Medicine, 1, 33.33%
General Medicine
1 publication, 33.33%
|
|
Pharmacology
|
Pharmacology, 1, 33.33%
Pharmacology
1 publication, 33.33%
|
|
Food Science
|
Food Science, 1, 33.33%
Food Science
1 publication, 33.33%
|
|
Neurology
|
Neurology, 1, 33.33%
Neurology
1 publication, 33.33%
|
|
Nutrition and Dietetics
|
Nutrition and Dietetics, 1, 33.33%
Nutrition and Dietetics
1 publication, 33.33%
|
|
Toxicology
|
Toxicology, 1, 33.33%
Toxicology
1 publication, 33.33%
|
|
Behavioral Neuroscience
|
Behavioral Neuroscience, 1, 33.33%
Behavioral Neuroscience
1 publication, 33.33%
|
|
Health (social science)
|
Health (social science), 1, 33.33%
Health (social science)
1 publication, 33.33%
|
|
1
|
Journals
|
1
|
|
|
Alcohol
1 publication, 33.33%
|
|
|
Journal of Functional Foods
1 publication, 33.33%
|
|
|
Phytotherapy Research
1 publication, 33.33%
|
|
|
1
|
Citing journals
|
1
2
3
|
|
|
Journal not defined
|
Journal not defined, 3, 8.82%
Journal not defined
3 citations, 8.82%
|
|
Phytotherapy Research
3 citations, 8.82%
|
|
|
Dermatologic Therapy
2 citations, 5.88%
|
|
|
Nutrients
2 citations, 5.88%
|
|
|
Alcohol
2 citations, 5.88%
|
|
|
Drugs and Drug Candidates
2 citations, 5.88%
|
|
|
Colloids and Surfaces B: Biointerfaces
1 citation, 2.94%
|
|
|
PeerJ
1 citation, 2.94%
|
|
|
Pharmacological Research
1 citation, 2.94%
|
|
|
Phytomedicine
1 citation, 2.94%
|
|
|
Medicinal Chemistry Research
1 citation, 2.94%
|
|
|
JAOCS, Journal of the American Oil Chemists' Society
1 citation, 2.94%
|
|
|
Annals of Medicine
1 citation, 2.94%
|
|
|
Experimental Eye Research
1 citation, 2.94%
|
|
|
Journal of Functional Foods
1 citation, 2.94%
|
|
|
Food and Function
1 citation, 2.94%
|
|
|
Journal of Ethnopharmacology
1 citation, 2.94%
|
|
|
Antioxidants
1 citation, 2.94%
|
|
|
Metabolites
1 citation, 2.94%
|
|
|
Current Drug Metabolism
1 citation, 2.94%
|
|
|
Food Chemistry
1 citation, 2.94%
|
|
|
Drug and Chemical Toxicology
1 citation, 2.94%
|
|
|
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
1 citation, 2.94%
|
|
|
Egyptian Liver Journal
1 citation, 2.94%
|
|
|
American Journal of Plant Sciences
1 citation, 2.94%
|
|
|
Experimental and Clinical Gastroenterology
1 citation, 2.94%
|
|
|
1
2
3
|
Publishers
|
1
2
|
|
|
Elsevier
2 publications, 66.67%
|
|
|
Wiley
1 publication, 33.33%
|
|
|
1
2
|
Organizations from articles
|
1
2
3
|
|
|
Creighton University
3 publications, 100%
|
|
|
Medical College and Hospital, Kolkata
1 publication, 33.33%
|
|
|
1
2
3
|
Countries from articles
|
1
2
3
|
|
|
USA
|
USA, 3, 100%
USA
3 publications, 100%
|
|
India
|
India, 3, 100%
India
3 publications, 100%
|
|
1
2
3
|
Citing organizations
Citing countries
|
2
4
6
8
10
|
|
|
China
|
China, 10, 29.41%
China
10 citations, 29.41%
|
|
USA
|
USA, 5, 14.71%
USA
5 citations, 14.71%
|
|
India
|
India, 5, 14.71%
India
5 citations, 14.71%
|
|
Country not defined
|
Country not defined, 4, 11.76%
Country not defined
4 citations, 11.76%
|
|
Egypt
|
Egypt, 2, 5.88%
Egypt
2 citations, 5.88%
|
|
Iran
|
Iran, 2, 5.88%
Iran
2 citations, 5.88%
|
|
Italy
|
Italy, 2, 5.88%
Italy
2 citations, 5.88%
|
|
Republic of Korea
|
Republic of Korea, 2, 5.88%
Republic of Korea
2 citations, 5.88%
|
|
Saudi Arabia
|
Saudi Arabia, 2, 5.88%
Saudi Arabia
2 citations, 5.88%
|
|
Russia
|
Russia, 1, 2.94%
Russia
1 citation, 2.94%
|
|
Austria
|
Austria, 1, 2.94%
Austria
1 citation, 2.94%
|
|
Brazil
|
Brazil, 1, 2.94%
Brazil
1 citation, 2.94%
|
|
United Kingdom
|
United Kingdom, 1, 2.94%
United Kingdom
1 citation, 2.94%
|
|
Spain
|
Spain, 1, 2.94%
Spain
1 citation, 2.94%
|
|
Canada
|
Canada, 1, 2.94%
Canada
1 citation, 2.94%
|
|
Malaysia
|
Malaysia, 1, 2.94%
Malaysia
1 citation, 2.94%
|
|
Nepal
|
Nepal, 1, 2.94%
Nepal
1 citation, 2.94%
|
|
UAE
|
UAE, 1, 2.94%
UAE
1 citation, 2.94%
|
|
Tunisia
|
Tunisia, 1, 2.94%
Tunisia
1 citation, 2.94%
|
|
2
4
6
8
10
|
- We do not take into account publications without a DOI.
- Statistics recalculated daily.